{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:43:17Z","timestamp":1791308597701,"version":"4.3.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1124\/jpet.114.219923","type":"journal-article","created":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T04:25:44Z","timestamp":1417580744000},"page":"305-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Pharmacological Characterization of a Novel Liver X Receptor Agonist with Partial LXR\u03b1 Activity and a Favorable Window in Nonhuman Primates"],"prefix":"10.1016","volume":"352","author":[{"given":"Todd G.","family":"Kirchgessner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sleph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lupisella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Smalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangaraj","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn H.","family":"Cantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Kick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.219923_bib1","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1074\/jbc.M510101200","article-title":"A novel principle for partial agonism of liver X receptor ligands. Competitive recruitment of activators and repressors","volume":"281","author":"Albers","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.219923_bib2","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1172\/JCI31909","article-title":"Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE","volume":"117","author":"Bradley","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.114.219923_bib3","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0022-2275(20)40677-7","article-title":"Critical tables for calculating the cholesterol saturation of native bile","volume":"19","author":"Carey","year":"1978","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.114.219923_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0378-1119(00)00518-7","article-title":"Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha)","volume":"262","author":"Chiang","year":"2001","journal-title":"Gene"},{"key":"10.1124\/jpet.114.219923_bib5","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopaual women","volume":"337","author":"Delmas","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.114.219923_bib6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/eurheartj\/ehr136","article-title":"Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis","volume":"33","author":"Giannarelli","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.114.219923_bib7","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1194\/jlr.M500116-JLR200","article-title":"Synthetic LXR agonists increase LDL in CETP species","volume":"46","author":"Groot","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.114.219923_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.atherosclerosis.2010.04.025","article-title":"LXRalpha regulates human CETP expression in vitro and in transgenic mice","volume":"212","author":"Honzumi","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1124\/jpet.114.219923_bib9","doi-asserted-by":"crossref","first-page":"21344","DOI":"10.1074\/jbc.M213202200","article-title":"Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor","volume":"278","author":"Inaba","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.219923_bib10","doi-asserted-by":"crossref","first-page":"45462","DOI":"10.1074\/jbc.M404744200","article-title":"The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c","volume":"279","author":"Jakel","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.219923_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1073\/pnas.96.1.266","article-title":"Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta","volume":"96","author":"Janowski","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.114.219923_bib12","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1073\/pnas.112059299","article-title":"Synthetic LXR ligand inhibits the development of atherosclerosis in mice","volume":"99","author":"Joseph","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.114.219923_bib13","doi-asserted-by":"crossref","unstructured":"Kick E, Martin R, Xie Y, Flatt B, Schweiger E, Wang TL, Busch B, Nyman M, Gu XH, Yan G, et al. (2014) Liver X Receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying LXR beta selectivity. Bioorg Med Chem Lett DOI:10.1016\/j.bmcl.2014.11.029.","DOI":"10.1016\/j.bmcl.2014.11.029"},{"key":"10.1124\/jpet.114.219923_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1073\/pnas.98.2.507","article-title":"LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes","volume":"98","author":"Laffitte","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.114.219923_bib15","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1074\/jbc.272.6.3137","article-title":"Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway","volume":"272","author":"Lehmann","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.219923_bib16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.bcp.2005.11.004","article-title":"Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype","volume":"71","author":"Lund","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.114.219923_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1172\/JCI8573","article-title":"Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element","volume":"105","author":"Luo","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.114.219923_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0092-8674(00)81432-4","article-title":"Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha","volume":"93","author":"Peet","year":"1998","journal-title":"Cell"},{"key":"10.1124\/jpet.114.219923_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.atherosclerosis.2009.07.016","article-title":"Differential effects of activation of liver X receptor on plasma lipid homeostasis in wild-type and lipoprotein clearance-deficient mice","volume":"208","author":"Peng","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1124\/jpet.114.219923_bib20","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1194\/jlr.M900037-JLR200","article-title":"LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse","volume":"50","author":"Quinet","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.114.219923_bib21","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1124\/mol.106.022608","article-title":"Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting","volume":"70","author":"Quinet","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.114.219923_bib22","doi-asserted-by":"crossref","first-page":"18793","DOI":"10.1074\/jbc.M109927200","article-title":"Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta","volume":"277","author":"Repa","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.219923_bib23","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"10.1124\/jpet.114.219923_bib24","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1101\/gad.850400","article-title":"Role of LXRs in control of lipogenesis","volume":"14","author":"Schultz","year":"2000","journal-title":"Genes Dev"},{"key":"10.1124\/jpet.114.219923_bib25","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.114.219923_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(02)03578-0","article-title":"T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice","volume":"536","author":"Terasaka","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.114.219923_bib27","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1210\/me.2003-0061","article-title":"Liver X receptor signaling pathways in cardiovascular disease","volume":"17","author":"Tontonoz","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1124\/jpet.114.219923_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-2275(20)39755-8","article-title":"Role of liver in the synthesis of cholesterol and the clearance of low density lipoproteins in the cynomolgus monkey","volume":"36","author":"Turley","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.114.219923_bib29","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1073\/pnas.200367697","article-title":"Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha","volume":"97","author":"Venkateswaran","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.114.219923_bib30","doi-asserted-by":"crossref","first-page":"14700","DOI":"10.1074\/jbc.275.19.14700","article-title":"Human white\/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols","volume":"275","author":"Venkateswaran","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.219923_bib31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jcmg.2011.11.025","article-title":"Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin","volume":"5","author":"Vucic","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1124\/jpet.114.219923_bib32","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1021\/jm800799q","article-title":"Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis","volume":"51","author":"Wrobel","year":"2008","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.114.219923_bib33","doi-asserted-by":"crossref","first-page":"15565","DOI":"10.1074\/jbc.M301311200","article-title":"Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8","volume":"278","author":"Yu","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.219923_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1168974","article-title":"LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor","volume":"325","author":"Zelcer","year":"2009","journal-title":"Science"},{"key":"10.1124\/jpet.114.219923_bib35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI27883","article-title":"Liver X receptors as integrators of metabolic and inflammatory signaling","volume":"116","author":"Zelcer","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.114.219923_bib36","doi-asserted-by":"crossref","first-page":"43018","DOI":"10.1074\/jbc.M107823200","article-title":"Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta","volume":"276","author":"Zhang","year":"2001","journal-title":"J Biol Chem"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418929X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418929X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.219923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:57:02Z","timestamp":1739987822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652418929X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S002235652418929X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.219923","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological Characterization of a Novel Liver X Receptor Agonist with Partial LXR\u03b1 Activity and a Favorable Window in Nonhuman Primates","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.219923","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}